Summary
Pathogenetix, Inc. (Pathogenetix), formerly U.S. Genomics is a subsidiary of Toxic Reports, LLC, medical device company that develops an automated system for rapid bacterial strain typing from complex samples. The company develops products and applications based on its proprietary Genome Sequence Scanning (GSS) technology, which detects bio-threat pathogens in environmental samples. It offers microbial genotyping system, which include benchtop instrument, targeted assays, and onboard bioinformatics. Pathogenetix’s bench top instrument integrate various components including genome processor for DNA sample preparation, genome classifier for automated data analysis, and genome scanner for stretching and scanning of DNA fragments, assay kits including salmonella and E.coli assay. The company serves food safety testing, industrial microbiology, clinical diagnostics and research markets. Pathogenetix is headquartered in Watertown, Massachusetts, the US.
Pathogenetix, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Pathogenetix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Pathogenetix, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Pathogenetix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Pathogenetix, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8
Pathogenetix, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Pathogenetix, Inc., Medical Equipment, Deal Details 10
Venture Financing 10
Pathogenetix Raises US$10 Million In Series C Financing 10
Pathogenetix Raises US$3.6 Million In Venture Financing 12
Pathogenetix Secures Additional US$7.5 Million In Series B Financing 13
Pathogenetix Secures US$1.51 Million In Venture Financing 15
U.S. Genomics Secures US$1.31 Million In Venture Financing 16
U.S. Genomics Secures US$1 Million In Venture Financing 17
Partnerships 18
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 18
Pathogenetix Enters Into Co-Development Agreement With Sagentia 20
Asset Transactions 21
Toxic Reports Acquires RESOLUTION Microbial Genotyping System from PathoGenetix 21
Pathogenetix, Inc. - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List of Tables
Pathogenetix, Inc., Medical Equipment, Key Facts 1
Pathogenetix, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Pathogenetix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Pathogenetix, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Pathogenetix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Pathogenetix, Inc., Deals By Market, 2010 to YTD 2016 8
Pathogenetix, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Pathogenetix Raises US$10 Million In Series C Financing 10
Pathogenetix Raises US$3.6 Million In Venture Financing 12
Pathogenetix Secures Additional US$7.5 Million In Series B Financing 13
Pathogenetix Secures US$1.51 Million In Venture Financing 15
U.S. Genomics Secures US$1.31 Million In Venture Financing 16
U.S. Genomics Secures US$1 Million In Venture Financing 17
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 18
Pathogenetix Enters Into Co-Development Agreement With Sagentia 20
Toxic Reports Acquires RESOLUTION Microbial Genotyping System from PathoGenetix 21
Pathogenetix, Inc., Key Competitors 22
Pathogenetix, Inc., Key Employees 23
List of Figures
Pathogenetix, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Pathogenetix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Pathogenetix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Pathogenetix, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Pathogenetix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Pathogenetix, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6
Pathogenetix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Pathogenetix, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8